Andrés Wigdorovitz

Dr. Andrés Wigdorovitz


Research Focus & Metrics

Academic Career Length

18Years (2009-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2018 in Virus Research
Verified
Journal Article
Closed access
VVVarusha Pillay Veerapen
Varusha Pillay Veerapen
Albertha van ZylAlbertha van Zyl
Albertha van Zyl
AWAndrés Wigdorovitz
Andrés Wigdorovitz
Edward Peter RybickiEdward Peter Rybicki
Edward Peter Rybicki
AMAnn Meyers
Ann Meyers

29 July 2020 in BMC Veterinary Research
Verified
Journal Article
Open access
PDF file
CVCelina Guadalupe Vega
Celina Guadalupe Vega
MBMarina Bok
Marina Bok
MEMaren Ebinger
Maren Ebinger
LRLucía Alejandra Rocha
Lucía Alejandra Rocha
ARAlejandra Antonella Rivolta
Alejandra Antonella Rivolta
AWAndrés Wigdorovitz
Andrés Wigdorovitz
Background: Neonatal diarrhea remains one of the main causes of morbi-mortality in dairy calves under artificial rearing. It is often caused by infectious agents of viral, bacterial, or parasitic origin. Cows vaccination and colostrum intake by calves during the first 6 h of life are critical strategies to prevent severe diarrhea but these are still insufficient. Here we report the field evaluation of a product based on IgY antibodies against group A rotavirus (RVA), coronavirus (CoV), enterotoxigenicEscherichia coli,andSalmonellasp. This product, named IgY DNT, has been designed as a complementary passive immunization strategy to prevent neonatal calf diarrhea. The quality of the product depends on the titers of specific IgY antibodies to each antigen evaluated by ELISA. In the case of the viral antigens, ELISA antibody (Ab) titers are correlated with protection against infection in calves experimentally challenged with RVA and CoV (Bok M, et al., Passive immunity to control bovine coronavirus diarrhea in a dairy herd in Argentina, 2017), (Vega C, et al., Vet Immunol Immunopathol, 142:156–69, 2011), (Vega C, et al., Res Vet Sci, 103:1–10, 2015). To evaluate the efficiency in dairy farms, thirty newborn Holstein calves were randomly assigned to IgY DNT or control groups and treatment initiated after colostrum intake and gut closure. Calves in the IgY DNT group received 20 g of the oral passive treatment in 2 L of milk twice a day during the first 2 weeks of life. Animals were followed until 3 weeks of age and diarrhea due to natural exposure to infectious agents was recorded during all the experimental time.Results: Results demonstrate that the oral administration of IgY DNT during the first 2 weeks of life to newborn calves caused a delay in diarrhea onset and significantly reduced its severity and duration compared with untreated calves. Animals treated with IgY DNT showed a trend towards a delay in RVA infection with significantly shorter duration and virus shedding compared to control calves.Conclusions: This indicates that IgY DNT is an effective product to complement current preventive strategies against neonatal calf diarrhea in dairy farms. Furthermore, to our knowledge, this is the only biological product available for the prevention of virus-associated neonatal calf diarrhea.

1 January 2009 in Vaccine
Verified
Journal Article
Closed access
DBDemian Bellido
Demian Bellido
PCPatricio O. Craig
Patricio O. Craig
MMMarina V. Mozgovoj
Marina V. Mozgovoj
DGDiego D. Gonzalez
Diego D. Gonzalez
AWAndrés Wigdorovitz
Andrés Wigdorovitz
MARIA JOSE DUS SANTOSMARIA JOSE DUS SANTOS
MARIA JOSE DUS SANTOS

6 August 2015 in Plant Biotechnology Journal
Verified
Journal Article
Open access
PDF file
VRVanesa Ruiz
Vanesa Ruiz
MMMarina V. Mozgovoj
Marina V. Mozgovoj
MSMaría José Dus Santos
María José Dus Santos
AWAndrés Wigdorovitz
Andrés Wigdorovitz
Summary: Vaccination has proved to be an efficient strategy to deal with viral infections in both human and animal species. However, protection of cattle against viral infections is still a major concern in veterinary science. During the last two decades, the development of efficient plant‐based expression strategies for recombinant proteins prompted the application of this methodology for veterinary vaccine purposes. The main goals of viral bovine vaccines are to improve the health and welfare of cattle and increase the production of livestock, in a cost‐effective manner. This review explores some of the more prominent recent advances in plant‐made viral bovine vaccines against foot‐and‐mouth disease virus (FMDV), bovine rotavirus (BRV), bovine viral diarrhoea virus (BVDV), bluetongue virus (BTV) and bovine papillomavirus (BPV), some of which are considered to be the most important viral causative agents of economic loss in cattle production.

28 September 2018 in Biotechnology Reports
Verified
Journal Article
Open access
VRVanesa Ruiz
Vanesa Ruiz
JBJosefina Baztarrica
Josefina Baztarrica
Edward Peter RybickiEdward Peter Rybicki
Edward Peter Rybicki
AMAnn Meyers
Ann Meyers
AWAndrés Wigdorovitz
Andrés Wigdorovitz
Foot-and-mouth disease (FMD) remains one of the most feared viral diseases affecting cloven-hoofed animals, and results in severe economic losses. Currently available vaccines are based on inactivated FMD virus (FMDV). The use of recombinant FMDV-like particles (VLPs) as subunit vaccines has gained importance because of their immunogenic properties and safety. We evaluated the production of FMD VLPs, via Agrobacterium-mediated transient expression, and the immunogenicity of these structures in mice. Leaves were infiltrated with pEAQ-HT and pRIC 3.0 vectors encoding the capsid precursor P1-2A and the protease 3C. The recombinant protein yield was 3–4 mg/kg of fresh leaf tissue. Both groups of mice immunized with purified VLPs and mice immunized with the crude leaf extract elicited a specific humoral response with similar antibody titers. Thus, minimally processed plant material containing transiently expressed FMD VLPs could be a scalable and cost-effective technology for the production of a recombinant subunit vaccine against FMDV.

18 June 2014 in Molecular Biotechnology
Verified
Journal Article
Closed access
PDF file
VRVanesa Ruiz
Vanesa Ruiz
AMA. C. Mignaqui
A. C. Mignaqui
MNM. C. Nuñez
M. C. Nuñez
ERE. Reytor
E. Reytor
JEJose M Escribano
Jose M Escribano
AWAndrés Wigdorovitz
Andrés Wigdorovitz